Inhibitory Potential of Six Brown Algae from the Persian Gulf on a-Glucosidase and In Vivo Antidiabetic Effect of Sirophysalis Trinodis
Open Access
- journal article
- research article
- Vol. 47 (5) , 484-493
Abstract
Background: Brown algae have gained worldwide attention due to their significant biological activities, such as antidiabetic properties. In the present study, the antidiabetic properties of six brown algae from the Persian Gulf were investigated. Methods: An experimental study was conducted from 2017 to 2019 to examine the inhibitory effects of six brown algae against the alpha-glucosidase activity. Methanol (MeOH) and 80% MeOH extracts of Colpomenia sinuosa, Sargassum acinaciforme, Iyengaria stellata, Sirophysalis trinodis, and two accessions of Polycladia myrica were analyzed. The effect of 80% MeOH extracts of Sirophysalis trinodis on blood glucose levels in streptozotocin-induced diabetic rats was evaluated. Chemical constituents of brown algae were analyzed using thin-layer chromatography and liquid chromatography-mass spectrometry techniques. Data were analyzed using SPSS software, and P < 0.05 was considered statistically significant. Results: The 80% MeOH extracts of Iyengaria stellata (IC50=0.33 +/- 0.15 mu g/mL) and Colpomenia sinuosa (IC50=3.50 +/- 0.75 mu g/mL) as well as the MeOH extracts of Colpomenia sinuosa (IC50=3.31 +/- 0.44 mu g/mL) exhibited stronger inhibitory effect on alpha-glucosidase than the acarbose (IC50=160.15 +/- 27.52 mu g/mL, P < 0.001). The 80% MeOH extracts of Sirophysalis trinodis reduced postprandial blood glucose levels in diabetic rats compared to the control group (P=0.037). Fucoxanthin was characterized as the major antidiabetic agent in most of the algal extracts. Conclusion: Sirophysalis trinodis is recommended as a novel source for isolation and identification of potential antidiabetic compounds due to its high in vivo and in vitro antidiabetic effects.Keywords
This publication has 25 references indexed in Scilit:
- In vitro and in vivo hypoglycemic effects of brown algal fucoidansInternational Journal of Biological Macromolecules, 2016
- Inhibition of α-glucosidase by new prenylated flavonoids from euphorbia hirta L. herbJournal of Ethnopharmacology, 2015
- Simultaneous Determination of Fucoxanthin and Its Deacetylated Metabolite Fucoxanthinol in Rat Plasma by Liquid Chromatography-Tandem Mass SpectrometryMarine Drugs, 2015
- Potential Bioactive Compounds from Seaweed for Diabetes ManagementMarine Drugs, 2015
- Efficacy and safety of a dieckol-rich extract (AG-dieckol) of brown algae, Ecklonia cava, in pre-diabetic individuals: a double-blind, randomized, placebo-controlled clinical trialFood & Function, 2015
- Biosynthetic Pathway and Health Benefits of Fucoxanthin, an Algae-Specific Xanthophyll in Brown SeaweedsInternational Journal of Molecular Sciences, 2013
- A Potential Commercial Source of Fucoxanthin Extracted from the Microalga Phaeodactylum tricornutumApplied Biochemistry and Biotechnology, 2012
- A randomised crossover placebo-controlled trial investigating the effect of brown seaweed (Ascophyllum nodosum and Fucus vesiculosus) on postchallenge plasma glucose and insulin levels in men and womenApplied Physiology, Nutrition, and Metabolism, 2011
- Selecting the “Right” Mouse Model for Metabolic Syndrome and Type 2 Diabetes Research2009
- ALPHA-GLUCOSIDASE INHIBITORSEndocrinology and Metabolism Clinics of North America, 1997